恒鑫生活 reported revenue of ¥0.94B for the period ended 2026-06-30, +7.4% year on year. Net income was ¥0.06B, a 6.8% net margin on a 18.5% gross margin. The largest revenue line is 可降解产品 at 48% of the total. Free cash flow for the period was ¥-0.15B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.94B | +7.4% |
| Gross profit | ¥0.17B | — |
| Operating income | ¥0.07B | — |
| Net income | ¥0.06B | -51.6% |
| Gross margin | 18.5% | Net margin 6.8% |
| Revenue Q/Q | +7.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 可降解产品 | ¥0.45B | 48.3% |
| 不可降解产品 | ¥0.45B | 48.0% |
| 其他业务 | ¥0.03B | 3.7% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.76B | 81.5% |
| R&D | ¥0.03B | 2.9% |
| SG&A | ¥0.07B | 7.1% |
| Tax & other | ¥0.01B | 1.1% |
| Item | Amount |
|---|---|
| Total assets | ¥2.81B |
| Total liabilities | ¥0.64B |
| Shareholders' equity | ¥2.16B |
| Equity / assets | 77.1% |
| Operating cash flow | ¥0.00B |
| Capital expenditure | ¥0.15B |
| Free cash flow | ¥-0.15B |
| Cash conversion (OCF / net income) | 106% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华阳智能 ・ 智迪科技 ・ 苏州规划 ・ 民生健康 ・ 中机认检 ・ 金凯生科 ・ 固高科技 ・ 德福科技 ・ 智信精密 ・ 尚水智能 ・ 港通医疗 ・ 中远通
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies